Home / Healthcare & Medicine / Antimicrobial & Antibiotic Resistance / Challenges in Antibiotic Resistance: Point Prevalence Surveys / Global PPS
Global PPS
Global PPS
Welcome. Here you will learn more about the aims and benefits of the global PPS of anti-microbial consumption and resistance. The worldwide global point prevalence survey on antibiotic consumption and resistance. What is it all about? It’s about data collection on antibiotic prescription patterns and resistance in the hospital. It’s about comparing data, nationally and worldwide. It’s about identifying targets to improve antibiotic prescribing in your hospital. What are the critical benefits of a PPS for the hospital and its patients? A PPS helps you to evaluate antimicrobial prescribing practices in your hospital, to identify targets to improve the quality of antimicrobial prescribing in your hospital, and to design hospital interventions in order to promote prudent antimicrobial prescribing.
The first global PPS was conducted in 2015. In total, 335 hospitals from 53 different countries participated. The bigger the dot, the more hospitals participated for that country. You can see here that most hospitals originated from European countries, but also several hospitals participated from America, Asia, Africa, as well as Australia and New Zealand. Let us now look at some more key benefits of the global PPS. We’ll give you four of them. The first one– the global PPS allows meaningful comparisons of antimicrobial consumption data. The global PPS offers a simple and standardised protocol as well as an in-house built, freely available web based tool for data entry and validation.
The standardised protocol and web-based tool renders the surveillance feasible and achievable to complete. Next, there is the quality assurance approach to the implementation of the data validation process. In order to achieve all of this, there is a central support towards data collection or other help participants might need. The helpdesks answers emails in a timely manner. There is a frequent asked questions list, an IT manual, et cetera, to support participants. The global PPS and its web-based programme allows repeated PPSs in time. As such, implemented interventions and actions at the local level in the hospital, can be assessed in order to evaluate whether antibiotic prescribing practices in hospitals improved in time. As you’ll see, this tool allows consistency and reproducibility in time.
The next key benefit for participants is that they receive real time feedback of their results. Participants provide efforts in collecting data. The collection of meaningful data is only valuable whenever local hospital data can be compared to other hospitals, other settings, or other regions. Whenever the data are entered and subsequently validated online onto the freely available global PPS programme, participants are able to download a comprehensive feedback, which compares hospital results to average results for the country, if at least three hospitals participated for that country. Next, the hospital results are compared to the region, as well as to average results for Europe. Here you see some examples. Feedback is provided through tables and graphs, such as bar charts and pie charts.
The next key benefit is networking, which is needed to achieve our common goals. The global PPS provides an opportunity to stimulate local networking. Of course, mutual cooperation and feedback is highly motivating for all partners. Further, through networking, we will continually improve health care quality. All together, we need to fight against antibiotic resistance and work towards improved antibiotic use for better patient healths. Indeed, this global PPS enhances sustained awareness. A last key benefits refers to the possibility to perform research, including hypothesis formulation. The global PPS enables in-depth interpretation of antimicrobial consumption data at different levels– geographical, institutional, and patient level. The global PPS enables the creation of a reference database for scientific research and hypothesis formulation at national and international level.
Yes, we encourage participants to work with their data. We further encourage data sharing in order to investigate specific research questions. For example, regarding haemato-oncology patients. Of course, data sharing is only done upon agreement with all partners. Further, we stimulate writing of abstracts, reports, scientific, peer-reviewed manuscripts. We need to share knowledge. If you are interested in your publication policy, please contact us on the email available at the end of this slide set. Are you convinced about the benefits for your hospital, for your patients, for yourself? This PPS method is simple and feasible. Participants to the 2015 global PPS were enthusiastic, as you can read here.
Someone from Saudi Arabia says, “Definitely, I will participate especially after we applied antimicrobial stewardship in a hospital, and this will give us comparative data before and after the intervention. This will be the third survey from my hospital.” Someone else from Belgium reported, “We just conducted a global PPS study. All patients have now also been entered into the database. We wanted to thank the helpdesk for their cooperation. As such, the study could run very smoothly.”
And read the following testimonial from Serbia, a country in South Europe. “We followed your advice and made a survey team. And it was such a nice opportunity for us to develop a nice interaction to further develop our extremely good cooperation. It was extremely useful that we surveyed to get most of the wards. It was easier than we expected. Staff were very collaborative and efficient, and we were very surprised how well it was achieved. Having in mind that we did not opt to distribute posters and other stuff. It seems that people liked and welcomed our action. We hope that we will continue to collaborate with you. We are looking forward for any kind of collaboration.” You are convinced?
You’re welcome to join us. Any hospital worldwide is welcome to participate. Together, we’ll fight against antimicrobial resistance.
Global PPS
As the article in Step 1.4 and the video in Step 1.5 explained, antimicrobial resistance is a global problem. Therefore, the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance has been developed. The Global PPS is unique in the sense that it provides additional information about microbiology and resistance rates.
The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (GLOBAL-PPS) is an ambitious project collecting data at a global level to monitor rates of antimicrobial prescribing in hospitalised patients. The project is funded by bioMérieux.
The GLOBAL-PPS establishes a global network for point prevalence surveys and aims to include as many hospitals from as many countries from all continents. Through the Global PPS it is hoped to create global awareness about antibiotic use and resistance and be instrumental in planning and supporting national and local stewardship interventions in a range of resource and geographical settings.
The recommended dataset has been developed from the core data collected in the ESAC and ECDC European PPS.
Activity
Have a look at an example of a completed form.
Let us know in the comments below how you would encourage your hospital to get involved in a Global PPS.
This article is from the online course:
Challenges in Antibiotic Resistance: Point Prevalence Surveys
Created by
This article is from the free online
Challenges in Antibiotic Resistance: Point Prevalence Surveys
Reach your personal and professional goals
Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.
Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.
